Open access journal of the Ferrata-Storti Foundation, a non-profit organization
Letters to the Editor

Efficacy, safety, and health-related quality of life in transplant-ineligible newly diagnosed multiple myeloma patients receiving bortezomib maintenance therapy: a study of the Korean Multiple Myeloma Working Party (KMMWP-174 study)

Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; Division of Hematology, Department of Internal Medicine, Yonsei University College of Medicine, Severance Hospital
Pharmacometrics Institute for Practical Education and Training (PIPET), College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; Department of Pharmacology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; Division of Data Science, Catholic Research Network for Multiple Myeloma
Pharmacometrics Institute for Practical Education and Training (PIPET), College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; Department of Pharmacology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; Division of Data Science, Catholic Research Network for Multiple Myeloma
Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul
Division of Hematology, Department of Internal Medicine, Yonsei University College of Medicine, Severance Hospital
Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Hwasun, Jeollanam-do
Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Seoul
Department of Hematology-Oncology, Hallym University Medical Center, Hallym University College of Medicine, Anyang
Division of Hematology-Oncology, Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju
Division of Hematology-Oncology, Department of Internal Medicine, Ewha Womans University Medical Center Mokdong Hospital, Seoul
Department of Hematology-Oncology, Center for Hematologic Malignancy, National Cancer Center, Goyang
Department of Internal Medicine, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul
Division of Hemato-Oncology, Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, South Korea
Division of Hemato-Oncology, Department of Internal Medicine, Wonju Severance Christian Hospital
Division of Hematology-Oncology, Department of Internal Medicine, Biochemical Research Institution, Pusan National University Hospital, Pusan National University School of Medicine, Busan
Department of Internal Medicine, Kosin University College of Medicine, Kosin University Gospel Hospital, Busan
Department of Internal Medicine, Hematology and Oncology, Chungbuk National University, College of Medicine
Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul
Haematologica Early view Aug 7, 2025 https://doi.org/10.3324/haematol.2025.287889

Abstract

Not available.

Figures & Tables

Article Information

Early view : Letters to the Editor
 
DOI
https://doi.org/10.3324/haematol.2025.287889
Pubmed
40820811
 
Published
2025-08-07
Published By
Ferrata Storti Foundation, Pavia, Italy
Print ISSN
0390-6078
Online ISSN
1592-8721
 
Copyright & Usage
Copyright (c) 2025 Ferrata Storti Foundation
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Article Usage

Online Views
1436
PDF Downloads
234

Statistics from Altmetric.com

No Data
Navigate
For Authors
For Reviewers
For Advertisers
Education
Privacy
More
Copyright © 2025 by the Ferrata Storti Foundation | Web design ￫ | Development ￫
ISSN 0390-6078 print | ISSN 1592-8721 online